Author

Julie Lucifora

Lyon 1 UniversitéORCID 0000-0003-0482-7809Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

David DuranteliD· 4 shared Guillaume Passot· 3 shared Michel L. RivoireiD· 3 shared Anna SalvettiiD· 2 shared Emilie M. CharlesiD· 2 shared Florentin Pastor· 2 shared Aïlona Marcadet-Hauss· 1 shared Benoı̂t ChabotiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

David DurantelORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Preclinical antiviral study of a liver-targeted TLR1/2 agonist in an immune-competent mouse model of HBV infection

Fanny Charriaud, Myriam Lamrayah, Romain Barnault, Svenja Schuehle, Manon Desmares, Mathias F Heikenwälder, Julie Lucifora, Bernard Verrier, David Durantel

This study evaluates a liver-targeted TLR1/2 agonist nanoparticle formulation for HBV treatment, showing enhanced antiviral effects compared to free agonist in mice.

bioRxiv · May 27, 2026 · PreprintMicrobiology

An optimized model for HEV infection in the HepaRG cell line

Stacy Gellenoncourt, Marie Pellerin, Aïlona Marcadet-Hauss, Roxanne Fouillé, Michel L. Rivoire, Guillaume Passot, Julie Lucifora, David Durantel, Nicole Pavio, Virginie Doceul

This study shows that HepaRG cells can be infected by HEV without DMSO treatment, making them a suitable model for studying HEV and its interaction with hepatocyte innate immunity.

Journal of Virological Methods · Nov 27, 2025Peer-reviewedMicrobiology

THE DUAL-SPECIFICITY KINASE DYRK1A INTERACTS WITH THE HEPATITIS B VIRUS GENOME AND REGULATES THE PRODUCTION OF VIRAL RNA

Florentin Pastor, Emilie M. Charles, Chiara Di Vona, Maëlys Chapelle, Michel L. Rivoire, Guillaume Passot, Benoı̂t Chabot, Susana de la Luna, Julie Lucifora, David Durantel, Anna Salvetti

This study identifies DYRK1A as a kinase that interacts with HBV cccDNA and enhances HBV RNA production by regulating the enhancer 1/X promoter.

PLoS ONE · Oct 15, 2024Peer-reviewedMicrobiology

Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes

Florentin Pastor, Emilie M. Charles, Lucid Belmudes, Hélène Chabrolles, Marion Cescato, Michel L. Rivoire, Thomas Bürger, Guillaume Passot, David Durantel, Julie Lucifora, Yohann Couté, Anna Salvetti

This study identifies phosphorylation changes in host proteins induced by HBV infection in primary human hepatocytes, revealing an intrinsic anti-viral response involving DNA repair and RNA-binding proteins.

Frontiers in Microbiology · May 22, 2024Peer-reviewedMicrobiology